Expression of the tyrosine phosphatase Src homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 168, Issue 9, 2002, Pages 4511-4518

  Deng, Caishu ^a   Minguela, Alfredo ^a   Hussain, Rehana Z ^a   Lovett Racke, Amy E ^a   Radu, Caius ^a   Ward, E Sally ^a   Racke, Michael K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; EPITOPE; GAMMA INTERFERON; MYELIN BASIC PROTEIN; PEPTIDE; PROTEIN KINASE P60; PROTEIN TYROSINE PHOSPHATASE; PROTEOLIPID PROTEIN; T LYMPHOCYTE RECEPTOR; TETRAMER;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE MODEL; DISEASE SEVERITY; FEMALE; GENE DELETION; IMMUNIZATION; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SRC HOMOLOGY DOMAIN; STAINING; TH1 CELL;

EID: 0036569801     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.9.4511     Document Type: Article

References (48)

1. Immunological aspects of demyelinating diseases
2. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling
3. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection
4. The tyrosine phosphatase SHP-1 regulates thymocyte positive selection
5. Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes
6. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1
7. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds
8. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency
9. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology
10. Mutations in mice that influence natural killer (NK) cell activity
11. The mouse mutant "moth-eaten." II. Functional studies of the immune system
12. The mouse mutant "moth-eaten." I. Development of lymphocyte populations
13. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins
14. "Viable motheaten," a new allele at the motheaten locus I. Pathology
15. v)
16. v prothymocytes to generate thymocytes after intravenous transfer
17. v) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro
18. Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase
19. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice
20. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: Detection of potential HCP substrates in GM-CSF signal transduction
21. DNA-binding Abs from viable motheaten mutant mice: Implications for B cell tolerance
22. + B cells in viable moth-eaten and normal mice
23. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1
24. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase
25. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness
26. Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicate the protein tyrosine phosphatase SHP-1 in chemokine responses
27. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction
28. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice
29. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
30. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
31. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
32. u mice using peptide-MHC multimers
33. u, which confers susceptibility to experimental allergic encephalomyelitis
34. Negative selection during the peripheral immune response to antigen
35. Genetically determined murine models of immunodeficiency
36. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity
37. Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells
38. The src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells
39. Determinant spreading and dynamics of the autoimmune T cell repertoire
40. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen
41. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells
42. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis
43. The functional significance of epitope spreading and its regulation by co-stimulatory molecules
44. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
45. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
46. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis
47. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease